New in PHEO: A Roadmap for Improving US Health Care
In these commentaries, members of the editorial board of Population Health, Equity & Outcomes present their ideas for fixes to the US health care system that could guide health policy efforts post election.
Latest News
View All
Semaglutide Linked to Reduced Health Care Expenses for Patients With Obesity, HF, ASCVD
FDA Q&A: Addressing Biosimilar Safety, AI in Drug Development, and Supply Chain Challenges
Fidanacogene Elaparvovec Shows Strong Results in Open-Label Phase 3 Study
Economic Burden in Late-Stage AMD High in Patients and Caregivers in US
Trump Recaptures White House, Spelling Uncertainty for Federal Health Policy
Nourishing Survival: The Impact of Dietary Quality on Black Women With Ovarian Cancer
Discrepancies Identified Between Patient Travel Patterns, Geographic Market Definitions
Digital Intervention Reduces Early Childhood Obesity Risk in Diverse Populations
Disparities in Cancer Mortality Among Asian Americans and Pacific Islanders
How the 2024 Election Will Determine the Future of America's Health Crises
Age, Race, Insurance Status Can Predict CV Mortality for Those With MPNs
Health Equity & Access Weekly Roundup: November 2, 2024
COVID-19 Leaves Lasting Impact on Nursing Practices and Job Satisfaction
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Key Takeaways on the Future of HER2 in NSCLC
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Implementing CRM Learnings and Utilization of Telehealth
Breast Cancer Challenges and Promises in Immunotherapy
Exploring the Differential Effectiveness of ICS by Smoking Status in COPD
Nourishing Survival: The Impact of Dietary Quality on Black Women With Ovarian Cancer
Removing Need for Switching Studies Could Change Payer Perspectives of Biosimilars
Integrating VMS Treatment Into Comprehensive Women’s Health Management
Improving Access and Equity in VMS Treatment
Proactive Care Management of AI-Identified At-Risk Patients Decreases Preventable Admissions
Privately Negotiated Facility Fees at Ambulatory Surgery Centers and Hospitals
Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional Medicare
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
The Daily Balancing Act of Value-Based Cancer Care
Transforming Value-Based Oncology Care in an Evolving Therapeutic Landscape
Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs
Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way
Navigating the Evolving Treatment Landscape of Metastatic Renal Cell Carcinoma
Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
